This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: CBST EOG LRN MRK PFE


Abercrombie & Fitch (ANF) was downgraded to hold at TheStreet Ratings.

Cubist (CBST) was upgraded at Mizuho to buy from neutral. $77 price target. Acquisitions should help drive near-term growth, Mizuho said.

C&J Energy (CJES) was downgraded at Cowen to market perform from outperform. $22.30 price target. Fracturing services market continues to suffer from chronic oversupply, Cowen said.

Ellington Financial (EFC) was upgraded to hold at TheStreet Ratings.

EOG Resources (EOG - Get Report) was upgraded at Credit Suisse to outperform from neutral. $175 price target. Estimates were also increased, given higher oil production forecasts, Credit Suisse said.

Iberiabank (IBKC) was downgraded at Oppenheimer to perform from outperform. Company is seeing pressure in mortgage banking, Oppenheimer said.

K12 (LRN - Get Report) was downgraded at Robert Baird to neutral from outperform. $25 price target. Company slashed its guidance, Baird said.

K12 was downgraded at BMO Capital to market perform from outperform. $22 price target. Company is seeing lower enrollment growth, BMO Capital said.

Masco (MAS) was upgraded at J.P. Morgan to overweight from neutral. $21 price target. Valuation is reasonable against unaggressive 2015 estimates, J.P. Morgan said.

Merck (MRK - Get Report) was initiated with a neutral rating at Credit Suisse. $49 price target. Core franchises are facing growth challenges, Credit Suisse said.

Owens Corning (OC) was upgraded at J.P. Morgan to overweight from neutral. $45 price target. More constructive view on repair/remodel focused building product names, J.P. Morgan said.

Pfizer (PFE - Get Report) was initiated with an outperform rating at Credit Suisse. $34 price target. Restructuring story will likely continue to evolve, Credit Suisse said.

Patterson-UTI (PTEN) was downgraded at Cowen to perform from outperform. $24 price target. Pressure pumping prices will likely show no improvement, Cowen said.

Viropharma (VPHM) was downgraded at Mizuho to neutral from buy. Valuation call, based on a $39 price target, Mizuho said.

Stock Comments / EPS Changes

Hain Celestial (HAIN) estimates were cut at Jefferies through 2013. Guidance below consensus at analyst day, Jefferies said. Buy rating and $91 price target.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CBST $101.94 0.14%
EOG $90.56 0.00%
LRN $15.99 0.00%
MRK $57.75 0.00%
PFE $34.53 0.00%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs